RAC
Click for more information
0.60% $1.69 race oncology ltd

Ann: Zantrene AML trial in Israel advances to Phase 2, page-126

  1. Stevenjoshua
    364 Posts.
    lightbulb Created with Sketch. 170
    clock Created with Sketch.
    15/07/23
    08:21
    Post #: 68800536
    He didn’t say AML was not on an approval pathway. He said the Sheba trial wasn’t. Because Bisantrene is being used in conbo compared to historical trials being single agent.
    RAC Price at posting: $1.60 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 16  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS $2.2M Placement to Expand Resources and Continue Exploration
right-arrow Created with Sketch.
NEWS TRENDING: High grade drilling assays
right-arrow Created with Sketch.
NEWS A$17 Million Cash Sale of Citadel Joint Venture Interest
right-arrow Created with Sketch.
NEWS PLS: HotCopper's Most Discussed Stock of The Week!
right-arrow Created with Sketch.
NEWS US fracking support boosts outlook for Australian gas stocks
right-arrow Created with Sketch.
NEWS Week 37 Wrap: HotCopper likes Cuban oil; markets shrug debate off for Putin; firebrand quant says social media a market threat
right-arrow Created with Sketch.
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.69 		Change
0.010(0.60%) 		Mkt cap ! $287.1M
Open High Low Value Volume
$1.69 $1.70 $1.65 $89.01K 53.2K

Buyers (Bids)

No. Vol. Price($)
1 2342 $1.69
 

Sellers (Offers)

Price($) Vol. No.
$1.70 5 1
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.